1. Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, Fox CB.. (1991) Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds., 34 (10): [PMID:1681106] [10.1021/jm00114a018] |
2. Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, Fox CB.. (1991) Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds., 34 (10): [PMID:1681106] [10.1021/jm00114a018] |
3. Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, Fox CB.. (1991) Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds., 34 (10): [PMID:1681106] [10.1021/jm00114a018] |
4. Chenard BL, Bordner J, Butler TW, Chambers LK, Collins MA, De Costa DL, Ducat MF, Dumont ML, Fox CB, Mena EE.. (1995) (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses., 38 (16): [PMID:7636876] [10.1021/jm00016a017] |
5. Chenard B, Butler T, Shalaby I, Prochniak M, Koe B, Fox C. (1993) Oxindole N-Methyl-D-Aspartate (NMDA) antagonists, 3 (1): [10.1016/S0960-894X(00)80098-0] |
6. Kawai M, Nakamura H, Sakurada I, Shimokawa H, Tanaka H, Matsumizu M, Ando K, Hattori K, Ohta A, Nukui S, Omura A, Kawamura M.. (2007) Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity., 17 (20): [PMID:17768047] [10.1016/j.bmcl.2007.08.039] |
7. Gawaskar S, Schepmann D, Bonifazi A, Robaa D, Sippl W, Wünsch B.. (2015) Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-position., 25 (24): [PMID:26531150] [10.1016/j.bmcl.2015.10.076] |
8. Dey S, Schepmann D, Wünsch B.. (2016) Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold., 26 (3): [PMID:26750254] [10.1016/j.bmcl.2015.12.067] |
9. Lütnant I, Schepmann D, Wünsch B.. (2016) Benzimidazolone bioisosteres of potent GluN2B selective NMDA receptor antagonists., 116 [PMID:27061977] [10.1016/j.ejmech.2016.03.065] |
10. Rath S, Schepmann D, Wünsch B.. (2017) Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity., 25 (20): [PMID:28797770] [10.1016/j.bmc.2017.07.059] |
11. Zhang L, Zhao Y, Wang J, Yang D, Zhao C, Wang C, Ma C, Cheng M.. (2018) Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents., 151 [PMID:29604542] [10.1016/j.ejmech.2018.03.052] |
12. Zhang L, Quan J, Zhao Y, Yang D, Zhao Q, Liu P, Cheng M, Ma C.. (2019) Design, synthesis and biological evaluation of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives as novel neuroprotective agents., 182 [PMID:31494474] [10.1016/j.ejmech.2019.111654] |
13. Bechthold E,Schreiber JA,Lehmkuhl K,Frehland B,Schepmann D,Bernal FA,Daniliuc C,Álvarez I,Garcia CV,Schmidt TJ,Seebohm G,Wünsch B. (2021) Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity., 64 (2.0): [PMID:33426889] [10.1021/acs.jmedchem.0c01912] |